Literature DB >> 16226542

Transient serous retinal detachment in classic and occult choroidal neovascularization after photodynamic therapy.

Stefan Mennel1, Carsten H Meyer, Fred Eggarter, Silvia Peter.   

Abstract

PURPOSE: To quantify transient serous retinal detachment in classic and occult choroidal neovascularization (CNV) after photodynamic therapy (PDT).
DESIGN: Prospective consecutive case series.
METHODS: Consecutive patients with classic and occult CNV were examined by optical coherence tomography before PDT and at 2 and 7 days after PDT.
RESULTS: In classic CNV (n = 6), retinal elevations increased from 217 (SD 42) microm before PDT to 626 (SD 157) microm 2 days after PDT and decreased to 240 (SD 36) microm 7 days after treatment. In occult CNV (n = 4), the mean retinal elevation of 266 (SD 41) microm before PDT increased to 544 (SD 94) microm 2 days after PDT and decreased to 259 (SD 40) microm 7 days after treatment.
CONCLUSION: Cross-sectional optical coherence tomography imaging revealed transient subretinal fluid accumulation in classic as well as in occult CNV after PDT. The subretinal location possibly relates to an outer blood-retinal barrier breakdown after PDT.

Entities:  

Mesh:

Year:  2005        PMID: 16226542     DOI: 10.1016/j.ajo.2005.04.041

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  10 in total

1.  High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy.

Authors:  J C Schmidt; S Mennel; S Hörle; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

2.  Which treatment is best for which AMD patient?

Authors:  P Kroll; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

3.  Transient serous retinal detachment after photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Hideaki Tobita; Kyoko Ohno-Matsui; Manabu Ogawa; Yuh Kaneko; Noriaki Shimada; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

4.  Serous retinal detachment following combined photodynamic therapy and intravitreal bevacizumab injection.

Authors:  Eui Yon Kim; Jong Wan Kim; Jun Bum Kim; Ho Min Lew
Journal:  Korean J Ophthalmol       Date:  2009-06-09

5.  Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro.

Authors:  R Obata; A Iriyama; Y Inoue; H Takahashi; Y Tamaki; Y Yanagi
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

6.  Effect of photodynamic therapy on the function of the outer blood-retinal barrier in an in vitro model.

Authors:  Stefan Mennel; Silvia Peter; Carsten H Meyer; Gabriele Thumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-19       Impact factor: 3.117

7.  Photodynamic therapy for retinal capillary hemangioma.

Authors:  V P Papastefanou; S Pilli; A Stinghe; A J Lotery; V M L Cohen
Journal:  Eye (Lond)       Date:  2013-01-04       Impact factor: 3.775

8.  Oscillatory photodynamic therapy for choroidal neovascularization and central serous retinopathy; a pilot study.

Authors:  Gholam A Peyman; Michael Tsipursky; Nariman Nassiri; Mandi Conway
Journal:  J Ophthalmic Vis Res       Date:  2011-07

9.  Transient increased exudation after photodynamic therapy of intraocular tumors.

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

10.  Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration.

Authors:  Min Ho Kim; Yoo-Ri Chung; Ji Hun Song
Journal:  BMC Ophthalmol       Date:  2021-02-22       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.